Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease

por LU, LEI, TANG, LE, WEI, WENSHI, HONG, YUNYI, CHEN, HEYU, YING, WEIHAI, CHEN, SHENGDI
Publicado 2014

NAD(+)-Carrying Mesoporous Silica Nanoparticles Can Prevent Oxidative Stress-Induced Energy Failures of Both Rodent Astrocytes and PC12 Cells

por Chen, Heyu, Wang, Yao, Zhang, Jixi, Ma, Yingxin, Wang, Caixia, Zhou, Ying, Gu, Hongchen, Ying, Weihai
Publicado 2013

Identification of Centella asiatica's Effective Ingredients for Inducing the Neuronal Differentiation

por Jiang, Hui, Zheng, Guoshuai, Lv, Junwei, Chen, Heyu, Lin, Jinjin, Li, Yiyang, Fan, Guorong, Ding, Xianting
Publicado 2016

Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

por Kang, Xunlei, Kim, Jaehyup, Deng, Mi, John, Samuel, Chen, Heyu, Wu, Guojin, Phan, Hiep, Zhang, Cheng Cheng
Publicado 2015

Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer

por Deng, Mi, Chen, Heyu, Liu, Xiaoye, Huang, Ryan, He, Yubo, Yoo, Byounggyu, Xie, Jingjing, John, Samuel, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng
Publicado 2021

LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axis

por Wu, Guojin, Xu, Yixiang, Schultz, Robbie D, Chen, Heyu, Xie, Jingjing, Deng, Mi, Liu, Xiaoye, Gui, Xun, John, Samuel, Lu, Zhigang, Arase, Hisashi, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng
Publicado 2021

CAMKs support development of acute myeloid leukemia

por Kang, Xunlei, Cui, Changhao, Wang, Chen, Wu, Guojin, Chen, Heyu, Lu, Zhigang, Chen, Xiaoli, Wang, Li, Huang, Jie, Geng, Huimin, Zhao, Meng, Chen, Zhengshan, Müschen, Markus, Wang, Huan-You, Zhang, Cheng Cheng
Publicado 2018

Blocking LAIR1 signaling in immune cells inhibits tumor development

por Xie, Jingjing, Gui, Xun, Deng, Mi, Chen, Heyu, Chen, Yuanzhi, Liu, Xiaoye, Ku, Zhiqiang, Tan, Lingxiao, Huang, Ryan, He, Yubo, Zhang, Bruce, Lewis, Cheryl, Chen, Kenian, Xu, Lin, Xu, Jian, Huang, Tao, Liao, X. Charlene, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng
Publicado 2022

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells

por Chen, Heyu, Chen, Yuanzhi, Deng, Mi, John, Samuel, Gui, Xun, Kansagra, Ankit, Chen, Weina, Kim, Jaehyup, Lewis, Cheryl, Wu, Guojin, Xie, Jingjing, Zhang, Lingbo, Huang, Ryan, Liu, Xiaoye, Arase, Hisashi, Huang, Yang, Yu, Hai, Luo, Wenxin, Xia, Ningshao, Zhang, Ningyan, An, Zhiqiang, Zhang, Cheng Cheng
Publicado 2020

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration

por Deng, Mi, Gui, Xun, Kim, Jaehyup, Xie, Li, Chen, Weina, Li, Zunling, He, Licai, Chen, Yuanzhi, Chen, Heyu, Luo, Weiguang, Lu, Zhigang, Xie, Jingjing, Churchill, Hywyn, Xu, Yixiang, Zhou, Zhan, Wu, Guojin, Yu, Chenyi, John, Samuel, Hirayasu, Kouyuki, Nguyen, Nam, Liu, Xiaoye, Huang, Fangfang, Li, Leike, Deng, Hui, Tang, Haidong, Sadek, Ali H., Zhang, Lingbo, Huang, Tao, Zou, Yizhou, Chen, Benjamin, Zhu, Hong, Arase, Hisashi, Xia, Ningshao, Jiang, Youxing, Collins, Robert, You, M. James, Homsi, Jade, Unni, Nisha, Lewis, Cheryl, Chen, Guo-Qiang, Fu, Yang-Xin, Liao, X. Charlene, An, Zhiqiang, Zheng, Junke, Zhang, Ningyan, Zhang, Cheng Cheng
Publicado 2018